A NOVEL POLYPEPTIDE-HUMAN CELL DIFFERENCIATION TRANSCRIPTION FACTOR 16 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE

摘要

The invention disclosed a new kind of polypeptide-human cell differenciation transcription factor 16 and the polynucleotide encoding said polypeptide and a process for producing the polypeptide by recombinant methods. It also disclosed the method of applying the polypeptide for the treatment of various kinds of diseases, such as cancer, hemopathy, HIV infection, immune diseases and inflammation. The antagonist of the polypeptide and therapeutic use of the same is also disclosed. In addition, it refers to the use of polynucleotide encoding said human cell differenciation transcription factor 16.